Works matching IS 01676997 AND DT 2007 AND VI 25 AND IP 3

Results: 14

Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: Comparative studies against doxorubicin and mitoxantrone.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 187, doi. 10.1007/s10637-007-9037-8

By:

Cavalletti, Ennio;
Crippa, Luca;
Mainardi, Patrizia;
Oggioni, Norberto;
Cavagnoli, Rosanna;
Bellini, Ornella;
Sala, Franca

Publication type:

Article

Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 277, doi. 10.1007/s10637-006-9032-5

By:

Stein, C. A.;
Goel, Sanjay;
Ghavamian, Reza

Publication type:

Article

Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 279, doi. 10.1007/s10637-006-9030-7

By:

Veltkamp, Stephan A.;
Meerum Terwogt, Jetske M.;
van den Heuvel, Michel M.;
van Boven, Hester H.;
Schellens, Jan H. M.;
Rodenhuis, Sjoerd

Publication type:

Article

Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 271, doi. 10.1007/s10637-006-9029-0

By:

Zhao, Liangli;
Marshall, Elaine S.;
Kelland, Lloyd R.;
Baguley, Bruce C.

Publication type:

Article

Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 237, doi. 10.1007/s10637-006-9028-1

By:

Goel, Sanjay;
Desai, Kavita;
Karri, Sirisha;
Gollamudi, Radharani;
Chaudhary, Imran;
Bulgaru, Anca;
Kaubisch, Andreas;
Goldberg, Gary;
Einstein, Mark;
Camacho, Fernando;
Baker, Sharyn;
Mani, Sridhar

Publication type:

Article

Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 227, doi. 10.1007/s10637-006-9027-2

By:

Kuppens, I. E. L. M.;
Witteveen, P. O.;
Schot, M.;
Schuessler, V. M.;
Daehling, A.;
Beijnen, J. H.;
Voest, E. E.;
Schellens, J. H. M.

Publication type:

Article

Transport of a novel anti-cancer agent, fenretinide across Caco-2 monolayers.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 197, doi. 10.1007/s10637-006-9026-3

By:

Kokate, Amit;
Li, Xiaoling;
Jasti, Bhaskara

Publication type:

Article

Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 211, doi. 10.1007/s10637-006-9025-4

By:

Kalmadi, S.;
Davis, M.;
Dowlati, A.;
O’Keefe, S.;
Cline-Burkhardt, M.;
Pelley, R. J.;
Borden, E.;
Dreicer, R.;
Bukowski, R.;
Mekhail, T.

Publication type:

Article

A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 217, doi. 10.1007/s10637-006-9021-8

By:

Baetz, Tara;
Eisenhauer, Elizabeth;
Siu, Lillian;
MacLean, Martha;
Doppler, Karen;
Walsh, Wendy;
Fisher, Bryn;
Khan, Azhar Z.;
de Alwis, Dinesh P.;
Weitzman, A.;
Brail, Leslie H.;
Moore, Malcolm

Publication type:

Article

Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 265, doi. 10.1007/s10637-006-9020-9

By:

Galsky, Matthew D.;
Mironov, Svetlana;
Iasonos, Alexia;
Scattergood, Joseph;
Boyle, Mary G.;
Bajorin, Dean F.

Publication type:

Article

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 253, doi. 10.1007/s10637-006-9012-9

By:

Yana, Takashi;
Negoro, Shunichi;
Takada, Minoru;
Yokota, Soichiro;
Takada, Yoshiki;
Sugiura, Takahiko;
Yamamoto, Hidehiko;
Sawa, Toshiyuki;
Kawahara, Masaaki;
Katakami, Nobuyuki;
Ariyoshi, Yutaka;
Fukuoka, Masahiro

Publication type:

Article

A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 247, doi. 10.1007/s10637-006-9014-7

By:

Kefford, Richard;
Beith, Jane McNeil;
Van Hazel, Guy Arthur;
Millward, Michael;
Trotter, James Marshall;
KeithWyld, David;
Kusic, Rada;
Shreeniwas, Revati;
Morganti, Adele;
Ballmer, Andrea;
Segal, Eleonor;
Nayler, Oliver;
Clozel, Martine

Publication type:

Article

Phase II Clinical and Pharmacologic Study of Radiation Therapy and Carboxyamido-triazole (CAI) in Adults with Newly Diagnosed Glioblastoma Multiforme.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 259, doi. 10.1007/s10637-006-9023-6

By:

Mikkelsen, Tom;
Lush, Richard;
Grossman, Stuart A.;
Carson, Kathryn A.;
Fisher, Joy D.;
Alavi, Jane B.;
Rosenfeld, Steve

Publication type:

Article

Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments.

Published in:

Investigational New Drugs, 2007, v. 25, n. 3, p. 205, doi. 10.1007/s10637-007-9038-7

By:

Axel-Rainer Hanauske;
Olaf Oberschmidt;
Hartmut Hanauske-Abel;
Michael Lahn;
Ulrike Eismann

Publication type:

Article